Mimedx (MDXG) EBT Growth (3y) (2014 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 32.79% |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 47.54% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -49.71% |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 12.01% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | 20.92% |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -1.05% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 48.67% |
| 10 | Mimedx | 530.69 Mn | 370.92 Mn | 41.62 Mn | -100.89% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -100.89% |
| Dec 31, 2025 | 30.27% |
| Sep 30, 2025 | 67.85% |
| Jun 30, 2025 | 47.42% |
| Mar 31, 2025 | 41.38% |
| Dec 31, 2024 | 398.15% |
| Sep 30, 2024 | 96.64% |
| Jun 30, 2024 | 146.69% |
| Mar 31, 2024 | 49.94% |
| Dec 31, 2023 | 40.79% |
| Sep 30, 2023 | 35.48% |
| Jun 30, 2023 | 45.61% |
| Mar 31, 2023 | 51.05% |
| Dec 31, 2022 | 49.76% |
| Sep 30, 2022 | -39.14% |
| Jun 30, 2022 | 14.30% |
| Mar 31, 2022 | 7.63% |
| Dec 31, 2021 | 26.21% |
| Sep 30, 2021 | -84.87% |
| Jun 30, 2021 | -44.16% |
| Mar 31, 2021 | -67.67% |
| Dec 31, 2020 | -43.11% |
| Sep 30, 2020 | -51.57% |
| Jun 30, 2020 | -47.28% |
| Mar 31, 2020 | -67.15% |
| Dec 31, 2019 | 6.69% |
| Sep 30, 2019 | 37.77% |
| Jun 30, 2019 | -91.08% |
| Mar 31, 2019 | -124.91% |
| Dec 31, 2018 | -46.37% |
| Sep 30, 2018 | -58.72% |
| Jun 30, 2018 | -31.83% |
| Mar 31, 2018 | -10.18% |
| Dec 31, 2017 | 59.70% |
| Sep 30, 2017 | 52.01% |
| Jun 30, 2017 | 169.89% |
| Mar 31, 2017 | 105.06% |
| Dec 31, 2016 | -84.42% |
| Sep 30, 2016 | 170.19% |
| Jun 30, 2016 | 87.15% |
| Mar 31, 2016 | 42.58% |
| Dec 31, 2015 | 89.31% |
| Sep 30, 2015 | 53.12% |
| Jun 30, 2015 | 112.51% |
| Mar 31, 2015 | 80.40% |
| Dec 31, 2014 | 56.07% |
| Sep 30, 2014 | 60.16% |
| Jun 30, 2014 | 45.74% |
| Mar 31, 2014 | 35.17% |